{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:45:37Z","timestamp":1792219537495,"version":"4.4.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00210-016-1252-4","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T23:27:27Z","timestamp":1462404447000},"page":"695-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Pleiotropic effects of statins: new therapeutic targets in drug design"],"prefix":"10.1007","volume":"389","author":[{"given":"Onkar","family":"Bedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,5]]},"reference":[{"issue":"3","key":"1252_CR1","first-page":"74","volume":"25","author":"M Abe","year":"2010","unstructured":"Abe M, Toyohara T, Ishii A, Suzuki T, Noguchi N, Akiyama Y, Shiwaku HO, Nakagomi-Hagihara R, Zheng G, Shibata E (2010) The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides. Drug Metab Pharmacokinet 25(3):74\u2013282","journal-title":"Drug Metab Pharmacokinet"},{"issue":"6","key":"1252_CR2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7150\/ijms.7.358","volume":"7","author":"F Alanazi","year":"2010","unstructured":"Alanazi F (2010) Pravastatin provides antioxidant activity and protection of erythrocytes loaded primaquine. Int J Med Sci 7(6):358","journal-title":"Int J Med Sci"},{"issue":"1-2","key":"1252_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1515\/znc-2003-1-211","volume":"58","author":"J Alarcon","year":"2003","unstructured":"Alarcon J, Aguila S, Arancibia-Avila P, Fuentes O, Zamorano-Ponce E, Hern\u00e1ndez M (2003) Production and purification of statins from Pleurotus ostreatus (Basidiomycetes) strains. Zeitschrift f\u00fcr Naturforschung C 58(1-2):62\u201364","journal-title":"Zeitschrift f\u00fcr Naturforschung C"},{"issue":"1","key":"1252_CR4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","volume":"286","author":"MA Albert","year":"2001","unstructured":"Albert MA, Danielson E, Rifai N, Ridker PM, Investigators P (2001) Effect of statin therapy on C-reactive protein levels, the pravastatin inflammation\/CRP evaluation (PRINCE), a randomized trial and cohort study. JAMA 286(1):64\u201370","journal-title":"JAMA"},{"issue":"2","key":"1252_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.0000080289.72166.CF","volume":"108","author":"MA Albert","year":"2003","unstructured":"Albert MA, Glynn RJ, Ridker PM (2003) Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 108(2):161\u2013165","journal-title":"Circulation"},{"issue":"2","key":"1252_CR6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","volume":"54","author":"R Altschul","year":"1995","unstructured":"Altschul R, Hoffer A, Stephen J (1995) Influence of nicotinic acid on serum cholesterol in man. Arch Biochem Biophys 54(2):558\u2013559","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"1252_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0006-291X(60)90266-7","volume":"2","author":"J Avigan","year":"1905","unstructured":"Avigan J, Steinberg D, Thompson MJ, Mosettig E (1905) Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesis. Biochem Biophys Res Commun 2(1):63\u201365","journal-title":"Biochem Biophys Res Commun"},{"key":"1252_CR8","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, et al. (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection), a randomised placebo-controlled trial. Lancet 377:2181\u20132192","journal-title":"Lancet"},{"issue":"2","key":"1252_CR9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","volume":"92","author":"B Banaszewska","year":"2007","unstructured":"Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ (2007) Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome, prospective, randomized, crossover trial. J Clin Endocrinol Metab 92(2):456\u2013461","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1252_CR10","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","volume":"105","author":"P Bar-On","year":"2008","unstructured":"Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, Spencer B, Masliah E (2008) Statins reduce neuronal \u03b1-synuclein aggregation in in vitro models of Parkinson\u2019s disease. J Neurochem 105(5):1656\u20131667","journal-title":"J Neurochem"},{"key":"1252_CR11","doi-asserted-by":"crossref","unstructured":"Bianchi, Stefano, Daniela Grimaldi and Roberto Bigazzi (2011) Statins and lipid-lowering strategies in cardiorenal patients 143-150","DOI":"10.1159\/000327139"},{"issue":"2","key":"1252_CR12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2011.07.023","volume":"56","author":"E Bj\u00f6rnsson","year":"2011","unstructured":"Bj\u00f6rnsson E, Jacobsen EI, Kalaitzakis E (2011) Hepatotoxicity associated with statin, reports of idiosyncratic liver injury post-marketing. J Hepatol 56(2):374\u2013380","journal-title":"J Hepatol"},{"issue":"1","key":"1252_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1755.2003.00744.x","volume":"63","author":"LM Blanco-Colio","year":"2003","unstructured":"Blanco-Colio LM, Tu\u00f1\u00f3n J, Mart\u00edn-Ventura JL, Egido J (2003) Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 63(1):12\u201323","journal-title":"Kidney Int"},{"issue":"8","key":"1252_CR14","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/me.2003-0327","volume":"18","author":"C Blanquart","year":"2004","unstructured":"Blanquart C, Mansouri R, Paumelle R, Fruchart JC, Staels B, Glineur C (2004) The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor \u03b1. Mol Endocrinol 18(8):1906\u20131918","journal-title":"Mol Endocrinol"},{"key":"1252_CR15","unstructured":"Bloch K (1964) Speech at the Nobel Banquet in Stockholm, December 10, 1964"},{"key":"1252_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.150.3692.19","volume":"150","author":"K Bloch","year":"1965","unstructured":"Bloch K (1965) The biological synthesis of cholesterol. Science 150:19\u201328","journal-title":"Science"},{"issue":"1","key":"1252_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0003-9861(59)90467-9","volume":"85","author":"TR Blohm","year":"1959","unstructured":"Blohm TR, Mac Kenzie RD (1959) Specific inhibition of cholesterol biosynthesis by a synthetic compound (MER-29). Arch Biochem Biophys 85(1):245\u2013249","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"1252_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jcmm.12422","volume":"19","author":"L Bonfrate","year":"2015","unstructured":"Bonfrate L, Procino G, Wang DQ, Svelto M, Portincasa P (2015) A novel therapeutic effect of statin on nephrogenic diabetes insipidus. J Cell Mol Med 19(2):265\u2013282","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1252_CR19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.RES.0000216039.75913.9e","volume":"98","author":"JH Brown","year":"2006","unstructured":"Brown JH, Del Re DP, Sussman MA (2006) The Rac and Rho hall of fame a decade of hypertrophic signaling hits. Circ Res 98(6):730\u2013742","journal-title":"Circ Res"},{"issue":"4746","key":"1252_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746):34\u201347","journal-title":"Science"},{"issue":"2","key":"1252_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0092-8674(04)00003-0","volume":"116","author":"K Burridge","year":"2004","unstructured":"Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116(2):167\u2013179","journal-title":"Cell"},{"key":"1252_CR22","first-page":"2387","volume":"25","author":"P Cannon Christopher","year":"2015","unstructured":"Cannon Christopher P, Michael A, Blazing Robert P, Giugliano AMC, Jennifer A, Theroux WP, Darius H, et al. (2015) Ezetimibe added to statin therapy after acute coronary syndromes. New Engl J Med 25:2387\u20132397","journal-title":"New Engl J Med"},{"issue":"6","key":"1252_CR23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","volume":"84","author":"E Carmina","year":"1999","unstructured":"Carmina E, Lobo RA (1999) Polycystic ovary syndrome (PCOS), arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897\u20131899","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1252_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2210-8-10","volume":"8","author":"SY Chan","year":"2008","unstructured":"Chan SY, Mancini GJ, Ignaszewski A, Frohlich J (2008) Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio, a randomized crossover study. BMC Pharmacol Toxicol 8(1):10","journal-title":"BMC Pharmacol Toxicol"},{"issue":"11","key":"1252_CR25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.0000056530.03783.81","volume":"107","author":"F Cipollone","year":"2003","unstructured":"Cipollone F, Fazia M, Iezzi A, et al. (2003) Suppression of the functionally coupled cyclooxygenase-2\/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation 107(11):1479\u20131485","journal-title":"Circulation"},{"key":"1252_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/oxfordjournals.bmb.a069687","volume":"14","author":"JW Cornforth","year":"1958","unstructured":"Cornforth JW, Popj\u00e1k G (1958) Biosynthesis of cholesterol. Br Med Bull 14:221\u2013226","journal-title":"Br Med Bull"},{"key":"1252_CR27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","volume":"84","author":"A Corsini","year":"1999","unstructured":"Corsini A, Bellosta S, Baetta R, Fumagalli R, Bernini F (1999) New insights into the pharmacodynamics and pharmacokinetic properties of statin. Pharmacol Ther 84:413\u2013428","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1252_CR28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2003.08.048","volume":"43","author":"R Corti","year":"2004","unstructured":"Corti R, Osende JI, Fallon JT, Fuster V, Mizsei G, Jneid H, Wright SD, Chaplin WF, Badimon JJ (2004) The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol 43(3):464\u2013473","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1252_CR29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000319647.15752.7b","volume":"71","author":"C Cramer","year":"2008","unstructured":"Cramer C, Haan M, Galea S, Langa K, Kalbfleisch J (2008) Use of statin and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 71(5):344\u2013350","journal-title":"Neurology"},{"key":"1252_CR30","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.4049\/jimmunol.172.12.7530","volume":"172","author":"R Cunard","year":"2004","unstructured":"Cunard R, Eto Y, Muljadi JT, Glass CK, Kelly CJ, Ricote M (2004) Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma. J Immunol 172:7530\u20137536","journal-title":"J Immunol"},{"issue":"6","key":"1252_CR31","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.4049\/jimmunol.126.6.2093","volume":"126","author":"J Cuthbert","year":"1981","unstructured":"Cuthbert J, Lipsky P (1981) Sterol metabolism and lymphocyte responsiveness, inhibition of endogenous sterol synthesis prevents mitogen-induced human T cell proliferation. J Immunol 126(6):2093\u20132099","journal-title":"J Immunol"},{"issue":"8","key":"1252_CR32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0192-0561(89)90107-0","volume":"11","author":"JL Cutts","year":"1989","unstructured":"Cutts JL, Bankhurst A (1989) Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by lovastatin. Int J Immunopharmacol 11(8):863\u2013869","journal-title":"Int J Immunopharmacol"},{"issue":"12","key":"1252_CR33","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1073\/pnas.122228799","volume":"99","author":"FR Danesh","year":"2002","unstructured":"Danesh FR, Sadeghi MM, Amro N, Philips C, Zeng L, Lin S, Sahai A, Kanwar YS (2002) 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase\/p21 signaling pathway, implications for diabetic nephropathy. Proc Natl Acad Sci 99(12):8301\u20138305","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"1252_CR34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00125-007-0919-2","volume":"51","author":"T Davis","year":"2008","unstructured":"Davis T, Yeap B, Davis W, Bruce D (2008) Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes, the Fremantle Diabetes Study. Diabetologia 51(4):562\u2013566","journal-title":"Diabetologia"},{"key":"1252_CR35","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/01.ATV.0000096207.01487.36","volume":"23","author":"S Deakin","year":"2003","unstructured":"Deakin S, Leviev I, Guernier S, et al. (2003) Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. ArterosclerThromb Vasc Biol 23:2083\u20132089","journal-title":"ArterosclerThromb Vasc Biol"},{"issue":"5","key":"1252_CR36","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/diabetes.54.5.1514","volume":"54","author":"LF Drel","year":"2005","unstructured":"Drel LF, VR Szab\u00f3 C, Stevens MJ, Obrosova IG (2005) Low-dose poly (ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy. Diabetes 54(5):1514\u20131522","journal-title":"Diabetes"},{"key":"1252_CR37","doi-asserted-by":"crossref","unstructured":"Devane GW, Czekala N, Judd HL, Yen SS (1975) Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol 121","DOI":"10.1016\/0002-9378(75)90081-2"},{"issue":"9","key":"1252_CR38","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/meta.2000.7716a","volume":"49","author":"AS Dobs","year":"2000","unstructured":"Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD (2000) Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism 49(9):1234\u20131238","journal-title":"Metabolism"},{"issue":"1","key":"1252_CR39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.thromres.2014.05.005","volume":"134","author":"H Du","year":"2014","unstructured":"Du H, Hu H, Zheng H, Hao J, Yang J, Cui W (2014) Effects of peroxisome proliferator-activated receptor \u03b3 in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases. Thromb Res 134(1):111\u2013120","journal-title":"Thromb Res"},{"issue":"7","key":"1252_CR40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4330\/wjc.v7.i7.404","volume":"7","author":"R DuBroff","year":"2015","unstructured":"DuBroff R, De Lorgeril M (2015) Cholesterol confusion and statin controversy. World J Cardiol 7(7):404","journal-title":"World J Cardiol"},{"issue":"4","key":"1252_CR41","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","volume":"85","author":"AJ Duleba","year":"2006","unstructured":"Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L (2006) Simvastatin improves biochemical parameters in women with polycystic ovary syndrome, results of a prospective, randomized trial. Fertil Steril 85(4):996\u20131001","journal-title":"Fertil Steril"},{"key":"1252_CR42","doi-asserted-by":"crossref","unstructured":"Ebrahim S, Taylor FC, Brindle P (2014) Statins for the primary prevention of cardiovascular disease. BMJ 348","DOI":"10.1136\/bmj.g280"},{"issue":"12","key":"1252_CR43","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.18632\/oncotarget.1376","volume":"4","author":"M Emilia","year":"2013","unstructured":"Emilia M, Carmona-Rodr\u00edguez L, Tard\u00e1guila M, Azcoitia I, Gonz\u00e1lez-Mart\u00edn A, Almonacid L, Casas J, Fabri\u00e1s G, Ma\u00f1es S (2013) A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors. Oncotarget 4(12):2288","journal-title":"Oncotarget"},{"key":"1252_CR44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7164\/antibiotics.29.841","volume":"8","author":"A Endo","year":"1976","unstructured":"Endo A, Kuroda M (1976) Citrinin, an inhibitor of cholesterol synthesis. J Antibiot 8:841","journal-title":"J Antibiot"},{"issue":"10","key":"1252_CR45","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1008-1050","volume":"14","author":"A Endo","year":"2008","unstructured":"Endo A (2008) A gift from nature, the birth of the statins. Nat Med 14(10):1050\u20131052","journal-title":"Nat Med"},{"key":"1252_CR46","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.7164\/antibiotics.29.1346","volume":"29","author":"A Endo","year":"1976","unstructured":"Endo A, Kuroda M, Tsujita Y (1976) ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J Antibiot 29:1346\u20131348","journal-title":"J Antibiot"},{"key":"1252_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1432-1033.1977.tb11637.x","volume":"77","author":"A Endo","year":"1977","unstructured":"Endo A, Tsujita T, Kuroda M, Tanzawa K (1977) Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutarylcoenzyme A reductase. Eur J Biochem 77:31\u201336","journal-title":"Eur J Biochem"},{"issue":"68","key":"1252_CR48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/1463-1741.127849","volume":"16","author":"A Ersoy","year":"2014","unstructured":"Ersoy A, Koc ER, Sahin S, Duzgun U, Acar B, Ilhan A (2014) Possible effects of rosuvastatin on noise-induced oxidative stress in rat brain. Noise Health 16(68):18","journal-title":"Noise Health"},{"key":"1252_CR49","doi-asserted-by":"crossref","unstructured":"Eslami L, Merat S, Malekzadeh R Nasseri-Moghaddam S & Aramin H (2013) Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. The Cochrane Library","DOI":"10.1002\/14651858.CD008623.pub2"},{"issue":"11","key":"1252_CR50","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.amjcard.2014.08.041","volume":"1114","author":"BM Everett","year":"2014","unstructured":"Everett BM, Mora S, Glynn RJ, MacFadyen J, Ridker PM (2014) Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30\u00a0mg\/dl) with rosuvastatin 20 mg daily (from JUPITER). Am J Cardiol 1114(11):1682\u20131689","journal-title":"Am J Cardiol"},{"issue":"3","key":"1252_CR51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.molmed.2014.12.008","volume":"21","author":"D Ferrari","year":"2015","unstructured":"Ferrari D, Vitiello L, Idzko M, la Sala A (2015) Purinergic signaling in atherosclerosis. Trends Mol Med 21(3):184\u2013192","journal-title":"Trends Mol Med"},{"issue":"4","key":"1252_CR52","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1749-6632.1956.tb36833.x","volume":"64","author":"JW Gofman","year":"1956","unstructured":"Gofman JW (1956) Serum lipoproteins and the evaluation of atherosclerosis. Ann N Y Acad Sci 64(4):590\u2013595","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1252_CR53","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0021-9258(19)51290-X","volume":"179","author":"JW Gofman","year":"1949","unstructured":"Gofman JW, Lindgren FT, Elliott H (1949) Ultracentrifugal studies of lipoproteins of human serum. J Biol Chem 179(2):973\u2013979","journal-title":"J Biol Chem"},{"key":"1252_CR54","unstructured":"Goldstein J, Brown MS (2003) Cholesterol, a century of research Howard Hughes. Med Inst Bull 16(3)"},{"issue":"4","key":"1252_CR55","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.00230.2003","volume":"285","author":"D Gregg","year":"2003","unstructured":"Gregg D, Rauscher FM, Goldschmidt-Clermont PJ (2003) Rac regulates cardiovascular superoxide through diverse molecular interactions, more than a binary GTP switch. Am J Phys Cell Physiol 285(4):C723\u2013C734","journal-title":"Am J Phys Cell Physiol"},{"key":"1252_CR56","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","volume":"44","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, BaireyMerz NC, et al. (2004) Implications of recent clinical trials for the NCEP adult treatment panel III guidelines. J Am Coll Cardiol 44:720\u2013722","journal-title":"J Am Coll Cardiol"},{"issue":"5372","key":"1252_CR57","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1126\/science.280.5372.2074","volume":"280","author":"A Hall","year":"1998","unstructured":"Hall A (1998) G proteins and small GTPases, distant relatives keep in touch. Science 280(5372):2074\u20132075","journal-title":"Science"},{"issue":"1","key":"1252_CR58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","volume":"19","author":"BA Hamelin","year":"1998","unstructured":"Hamelin BA, Turgeon J (1998) Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 19(1):26\u201337","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"1252_CR59","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1476-5381.2009.00125.x","volume":"156","author":"G Heeba","year":"2004","unstructured":"Heeba G, Moselhy M, Hassan M, Khalifa M, Gryglewski R, Malinski T (2004) Anti-atherogenic effect of statin s, role of nitric oxide, peroxynitrite and haem oxygenase-1. Br J Pharmacol 156(8):1256\u20131266","journal-title":"Br J Pharmacol"},{"issue":"10","key":"1252_CR60","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.bcp.2013.09.004","volume":"86","author":"T Hilbert","year":"2013","unstructured":"Hilbert T, Poth J, Frede S, Klaschik S, Hoeft A, Baumgarten G, Knuefermann P (2013) Anti-atherogenic effects of statin s, impact on angiopoietin-2 release from endothelial cells. Biochem Pharmacol 86(10):1452\u20131460","journal-title":"Biochem Pharmacol"},{"key":"1252_CR61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS (2002) SREBPs, activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125\u20131131","journal-title":"J Clin Invest"},{"issue":"3","key":"1252_CR62","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbrc.2006.03.036","volume":"343","author":"M Hsu","year":"2006","unstructured":"Hsu M, Muchova L, Morioka I, Wong RJ, Schr\u00f6der H, Stevenson DK (2006) Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343(3):738\u2013744","journal-title":"Biochem Biophys Res Commun"},{"issue":"6294","key":"1252_CR63","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","volume":"347","author":"I Issemann","year":"1990","unstructured":"Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347(6294):645\u2013650","journal-title":"Nature"},{"issue":"5519","key":"1252_CR64","first-page":"1160","volume":"292","author":"E Istvan","year":"2001","unstructured":"Istvan E, Deisenhofer S, Johann (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Sci Mag 292(5519):1160\u20131164","journal-title":"Sci Mag"},{"key":"1252_CR65","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","volume":"82","author":"D Izquierdo","year":"2004","unstructured":"Izquierdo D, Foyouzi N, Kwintkiewicz J, Duleba AJ (2004) Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis. Fertil Steril 82:1193\u20131197","journal-title":"Fertil Steril"},{"issue":"1","key":"1252_CR66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12883-015-0390-5","volume":"15","author":"JH Jeong","year":"2015","unstructured":"Jeong JH, Yum KS, Chang JY, Kim M, Ahn JY, Kim S, Han MK (2015) Dose-specific effect of simvastatin on hypoxia-induced HIF-1\u03b1 and BACE expression in Alzheimer\u2019s disease cybrid cells. BMC Neurol 15(1):127","journal-title":"BMC Neurol"},{"issue":"3","key":"1252_CR67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1535370213519215","volume":"239","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, Zhang Y, Zhang H, Zhu B, Li P, Lu C, Xu Y, Chen W, Lin N (2014) Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPAR\u03b3 expression and activating Wnt signaling pathway. Exp Biol Med 239(3):347\u2013355","journal-title":"Exp Biol Med"},{"issue":"2","key":"1252_CR68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11302-011-9289-9","volume":"8","author":"L Jing","year":"2012","unstructured":"Jing L, Fountain SJ (2012) Fluvastatin suppresses native and recombinant human P2X4 receptor function. Purinergic Signal 8(2):311\u2013316","journal-title":"Purinergic Signal"},{"key":"1252_CR69","unstructured":"John Simons (2003) The $10 Billion Pill Hold the fries, please Lipitor, the cholesterol-lowering drug, has become the bestselling pharmaceutical in history Here's how Pfizer did it FORTUNE Magazine ( http:\/\/archivefortune.com\/magazines\/fortune\/fortune_archive\/2003\/01\/20\/335643\/index.htm )"},{"key":"1252_CR70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrd1112","volume":"2","author":"A Jonathan","year":"2003","unstructured":"Jonathan A (2003) Lovastatin and beyond, the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov 2:517\u2013526","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"1252_CR71","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.STR.27.12.2230","volume":"27","author":"S Kalmijn","year":"1996","unstructured":"Kalmijn S, Feskens E, Launer L, Kromhout D (1996) Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 27(12):2230\u20132235","journal-title":"Stroke"},{"key":"1252_CR72","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/CIRCULATIONAHA.106.624890","volume":"114","author":"A Kashani","year":"2006","unstructured":"Kashani A, Phillips CO, Foody JM, et al. (2006) Risks associated with statin therapy, a systematic overview of randomized clinical trials. Circulation 114:2788\u20132797","journal-title":"Circulation"},{"issue":"13","key":"1252_CR73","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","volume":"8","author":"S Kinlay","year":"2003","unstructured":"Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P (2003) High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 8(13):1560\u20131566","journal-title":"Circulation"},{"issue":"4","key":"1252_CR74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.CIR.0000136588.62638.5E","volume":"110","author":"S Kinlay","year":"2004","unstructured":"Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P (2004) Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble. CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 110(4):386\u2013391","journal-title":"Circulation"},{"issue":"19","key":"1252_CR75","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.1994.00420190068008","volume":"154","author":"R Klein","year":"1994","unstructured":"Klein R, Klein BE, Moss SE, Cruickshanks KJ (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154(19):2169\u20132178","journal-title":"Arch Intern Med"},{"key":"1252_CR76","volume-title":"Statins prevent dextrose-induced endoplasmic reticulum stress and oxidative stress in endothelial and HepG2 cells","author":"H Kojanian","year":"2014","unstructured":"Kojanian H, Szafran-Swietlik A, Onstead-Haas LM, Haas MJ & Mooradian AD (2014) Statins prevent dextrose-induced endoplasmic reticulum stress and oxidative stress in endothelial and HepG2 cells. Am J Ther"},{"key":"1252_CR77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","volume":"1471","author":"A Kumar","year":"2012","unstructured":"Kumar A, Sharma N, Gupta A, Kalonia H, Mishra J (2012a) Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. Brain Res 1471:13\u201322","journal-title":"Brain Res"},{"issue":"6","key":"1252_CR78","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S1734-1140(12)70930-1","volume":"64","author":"A Kumar","year":"2012","unstructured":"Kumar A, Vashist A, Kumar P, Kalonia H, Mishra J (2012b) Protective effect of HMG CoA reductase inhibitors against running wheel activity induced fatigue, anxiety like behavior, oxidative stress and mitochondrial dysfunction in mice. Pharmacol Rep 64(6):1326\u20131336","journal-title":"Pharmacol Rep"},{"issue":"1","key":"1252_CR79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0162-3109(96)00108-7","volume":"34","author":"S Kurakata","year":"1996","unstructured":"Kurakata S, Kada M, Shimada Y, Komai T, Nomoto K (1996) Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro. Immunopharmacology 34(1):51\u201361","journal-title":"Immunopharmacology"},{"issue":"12","key":"1252_CR80","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","volume":"6","author":"B Kwak","year":"2000","unstructured":"Kwak B, Mulhaupt F, Myit S, Mach F (2000) Statin as a newly recognized type of immunomodulator. Nat Med 6(12):1399\u20131402","journal-title":"Nat Med"},{"key":"1252_CR81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2003.11.023","volume":"98","author":"WT Lai","year":"2005","unstructured":"Lai WT, Lee KT, Chu CS, et al. (2005) Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans, an effect independent on cholesterol elevation. Int J Cardiol 98:459\u2013464","journal-title":"Int J Cardiol"},{"issue":"4","key":"1252_CR82","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0008-6363(01)00540-5","volume":"53","author":"U Laufs","year":"2002","unstructured":"Laufs U, Kilter H, Konkol C, Wassmann S, B\u00f6hm M, Nickenig G (2002) Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res 53(4):911\u2013920","journal-title":"Cardiovasc Res"},{"issue":"12","key":"1252_CR83","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","volume":"97","author":"U Laufs","year":"1998","unstructured":"Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97(12):1129\u20131135","journal-title":"Circulation"},{"issue":"2","key":"1252_CR84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jbspin.2012.07.007","volume":"80","author":"PE Lazzerini","year":"2013","unstructured":"Lazzerini PE, Capperucci C, Spreafico A, Capecchi PL, Niccolini S, Ferrata P, Frediani B, Galeazzi M, Laghi-Pasini F (2013) Rosuvastatin inhibits spontaneous and IL-1\u03b2-induced interleukin-6 production from human cultured osteoblastic cells. Joint Bone Spine 80(2):195\u2013200","journal-title":"Joint Bone Spine"},{"issue":"10","key":"1252_CR85","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.0000140694.67251.9C","volume":"110","author":"T-S Lee","year":"2004","unstructured":"Lee T-S, Chang C-C, Zhu Y, Shyy JY (2004) Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110(10):1296\u20131302","journal-title":"Circulation"},{"key":"1252_CR86","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","volume":"32","author":"H Lennernas","year":"1997","unstructured":"Lennernas H, Fager G (1997) Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors, similarities and differences. Clin Pharmacokinet 32:403\u2013425","journal-title":"Clin Pharmacokinet"},{"issue":"9602","key":"1252_CR87","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","volume":"370","author":"S Lewington","year":"2007","unstructured":"Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure, a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370(9602):1829\u20131839","journal-title":"Lancet"},{"key":"1252_CR88","first-page":"489","volume":"78","author":"F Lynen","year":"1997","unstructured":"Lynen F (1997) The biochemical basis of the biosynthesis of cholesterol and fatty acids. Wien Klin Wochenschr 78:489\u2013497","journal-title":"Wien Klin Wochenschr"},{"issue":"13","key":"1252_CR89","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.0000091084.46500.BB","volume":"108","author":"C Maack","year":"2003","unstructured":"Maack C, Kartes T, Kilter H, Sch\u00e4fers HJ, Nickenig G, B\u00f6hm M, Laufs U (2003) Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 108(13):1567\u20131574","journal-title":"Circulation"},{"key":"1252_CR90","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijcard.2009.01.008","volume":"142","author":"N Mahajan","year":"2010","unstructured":"Mahajan N, Bahl A, Dhawan V (2010) C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin. Int J Cardiol 142:273\u2013278","journal-title":"Int J Cardiol"},{"key":"1252_CR91","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.arcmed.2010.04.005","volume":"41","author":"N Mahajan","year":"2010","unstructured":"Mahajan N, Dhawan V (2010) In vitro modulation of peroxisome proliferator-activated receptor-g and its genes by C-reactive protein role of atorvastatin. Arch Med Res 41:154\u2013161","journal-title":"Arch Med Res"},{"issue":"2","key":"1252_CR92","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ccl.2015.02.004","volume":"33","author":"KC Maki","year":"2015","unstructured":"Maki KC, Dicklin MR, Baum SJ (2015) Statins and diabetes. Cardiol Clin 33(2):233\u2013243","journal-title":"Cardiol Clin"},{"issue":"2","key":"1252_CR93","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1582-4934.2009.00986.x","volume":"15","author":"A Marzoll","year":"2011","unstructured":"Marzoll A, Melchior-Becker A, Cipollone F, Fischer JW (2011) Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment? J Cell Mol Med 15(2):232\u2013243","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1252_CR94","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/NCI.0b013e3181f7b4db","volume":"21","author":"S Merhaut","year":"2010","unstructured":"Merhaut S, Trupp RJ (2010) Cardiorenal dysfunction AACN. Adv Crit Care 21(4):357\u2013364","journal-title":"Adv Crit Care"},{"issue":"1","key":"1252_CR95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbrc.2007.10.148","volume":"365","author":"O Mistafa","year":"2008","unstructured":"Mistafa O, H\u00f6gberg J, Stenius U (2008) Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells. Biochem Biophys Res Commun 365(1):131\u2013136","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1252_CR96","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1743-6109.2008.01057.x","volume":"6","author":"A Morelli","year":"2009","unstructured":"Morelli A, Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E, Zhang XH, Vignozzi L, Vannelli GB, Forti G (2009) Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA\/Rho-kinase signaling hyperactivation. J Sex Med 6(1):91\u2013106","journal-title":"J Sex Med"},{"issue":"3","key":"1252_CR97","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.282.3.254","volume":"282","author":"JT Moroney","year":"1999","unstructured":"Moroney JT, Tang M-X, Berglund L, Small S, Merchant C, Bell K, Stern Y, Mayeux R (1999) Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 282(3):254\u2013260","journal-title":"JAMA"},{"issue":"4","key":"1252_CR98","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archinte.1939.00190040016002","volume":"64","author":"C Muller","year":"1939","unstructured":"Muller C (1939) Angina pectoris in hereditary xanthomatosis. Arch Intern Med 64(4):675","journal-title":"Arch Intern Med"},{"issue":"5446","key":"1252_CR99","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","volume":"286","author":"G Mundy","year":"1999","unstructured":"Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286(5446):1946\u20131949","journal-title":"Science"},{"key":"1252_CR100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-5273(00)00439-3","volume":"77","author":"J Musia\u0142","year":"2001","unstructured":"Musia\u0142 J, Undas A, Gajewski P, et al. (2001) Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol 77:247\u2013253","journal-title":"Int J Cardiol"},{"issue":"2","key":"1252_CR101","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.21564","volume":"54","author":"T Nagashima","year":"2006","unstructured":"Nagashima T, Okazaki H, Yudoh K, Matsuno H, Minota S (2006) Apoptosis of rheumatoid synovial cells by statin s through the blocking of protein geranylgeranylation, a potential therapeutic approach to rheumatoid arthritis. Arthritis Rheum 54(2):579\u2013586","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1252_CR102","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1242\/jcs.114.8.1555","volume":"114","author":"H Nakagawa","year":"2001","unstructured":"Nakagawa H, Miki H, Ito M, Ohashi K, Takenawa T, Miyamoto S (2001) N-WASP, WAVE and Mena play different roles in the organization of actin cytoskeleton in lamellipodia. J Cell Sci 114(8):1555\u20131565","journal-title":"J Cell Sci"},{"issue":"2","key":"1252_CR103","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/01.HYP.33.2.719","volume":"33","author":"P Nazzaro","year":"1999","unstructured":"Nazzaro P, Manzari M, Merlo M, Triggiani R, Scarano A, Ciancio L, Pirrelli A (1999) Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects. Hypertension 33(2):719\u2013725","journal-title":"Hypertension"},{"key":"1252_CR104","volume-title":"Hideyo Noguchi","author":"T Okumura","year":"1933","unstructured":"Okumura T (1933) Hideyo Noguchi. Iwanami Shoten, Tokyo in Japanese"},{"issue":"2","key":"1252_CR105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/17512433.2015.1011125","volume":"8","author":"H Okuyama","year":"2015","unstructured":"Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, Uchino H (2015) Statins stimulate atherosclerosis and heart failure, pharmacological mechanisms. Expert Rev Clin Pharmacol 8(2):189\u2013199","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1252_CR106","unstructured":"Olivia Williams, Anne-Marie Jacks, Jim Davis, Sabrina Martinez (1998) Case 10, Merck(A), Mevacor. In Allan Afuah. Innovation Management\u2014strategies, implementation, and profits. Oxford University Press ISBN 0-19-511346-2 Retrieved 2006-07-19"},{"issue":"1","key":"1252_CR107","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/oby.2007.19","volume":"16","author":"CL Oltman","year":"2008","unstructured":"Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Yorek MA (2008) Attenuation of vascular\/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin. Obesity 16(1):82\u201389","journal-title":"Obesity"},{"issue":"6","key":"1252_CR108","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/01.ASN.0000018400.39687.8C","volume":"13","author":"W Palinski","year":"2002","unstructured":"Palinski W, Tsimikas S (2002) Immunomodulatory effects of statin s, mechanisms and potential impact on arteriosclerosis. J Am Soc Nephrol 13(6):1673\u20131681","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1252_CR109","first-page":"190","volume":"21","author":"D Pella","year":"2005","unstructured":"Pella D, Rybar R, Mechirova V (2005) Pleiotropic effects of statin s. Acta Card Sin 21(4):190","journal-title":"Acta Card Sin"},{"issue":"2","key":"1252_CR110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jamainternmed.2014.6388","volume":"175","author":"JM Pe\u00f1a","year":"2015","unstructured":"Pe\u00f1a JM, Aspberg S, MacFadyen J, Glynn RJ, Solomon DH, Ridker PM (2015) Statin therapy and risk of fracture results from the JUPITER randomized clinical trial. JAMA Intern Med 175(2):171\u2013177","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1252_CR111","first-page":"246","volume":"106","author":"EV Perdices","year":"2014","unstructured":"Perdices EV, Medina-C\u00e1liz I, Hernando S, Ortega A, Mart\u00edn-Oca\u00f1a F, Navarro JM, Pel\u00e1ez G, Castiella A, Hallal H, Romero-G\u00f3mez M, Gonz\u00e1lez-Jim\u00e9nez A, Robles-D\u00edaz M, Lucena MI, Andrade RJ (2014) Hepatotoxicity associated with statin use, analysis of the cases included in the Spanish Hepatotoxicity Registry. Rev EspEnferm Dig 106(4):246\u2013254","journal-title":"Rev EspEnferm Dig"},{"key":"1252_CR112","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00424-011-1007-5","volume":"462","author":"G Procino","year":"2011","unstructured":"Procino G, Barbieri C, Carmosino M, Tamma G, Milano S, De Benedictis L, Grazia Mola M, Lazo-Fernandez Y, Valenti G, Svelto M (2011) Fluvastatin modulates renal water reabsorption in vivo through increased AQP2 availability at the apical plasma membrane of collecting duct cells Pflugers. Arch Eur J Physiol 462:753\u2013766","journal-title":"Arch Eur J Physiol"},{"key":"1252_CR113","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1042\/bj3220893","volume":"322","author":"M Racchi","year":"1997","unstructured":"Racchi M, Baetta R, Salvietti N, Ianna P, Franceschini G, Paoletti R, Fumagalli R, Govoni S, Trabucchi M, Soma M (1997) Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J 322:893\u2013896","journal-title":"Biochem J"},{"issue":"3","key":"1252_CR114","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s13105-013-0240-0","volume":"69","author":"SVVS Ramanjaneyulu","year":"2013","unstructured":"Ramanjaneyulu SVVS, Trivedi PP, Kushwaha S, Vikram A, Jena GB (2013) Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice. J Physiol Biochem 69(3):513\u2013525","journal-title":"J Physiol Biochem"},{"key":"1252_CR115","first-page":"178","volume":"3","author":"SK Rao","year":"2011","unstructured":"Rao SK, Prasad T, Mohanta GP, Manna PK (2011) An overview of statins as hypolipidemic drugs. Int J Pharm Sci Drug Res 3:178\u2013183","journal-title":"Int J Pharm Sci Drug Res"},{"issue":"6","key":"1252_CR116","first-page":"G962","volume":"298","author":"S Rattan","year":"2010","unstructured":"Rattan S (2010) 3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA\/ROCK pathway regulated by RhoA prenylation. Am J Physiol-Gastr L 298(6):G962\u2013G969","journal-title":"Am J Physiol-Gastr L"},{"key":"1252_CR117","doi-asserted-by":"crossref","unstructured":"Ravnskov U, Rosch PJ, McCully KS (2015) Statins do not protect against cancer: quite the opposite. J Clin Oncol JCO-2014","DOI":"10.1200\/JCO.2014.58.9564"},{"issue":"4","key":"1252_CR118","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","volume":"7","author":"LM Refolo","year":"2000","unstructured":"Refolo LM, Pappolla MA, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K (2000) Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7(4):321\u2013331","journal-title":"Neurobiol Dis"},{"key":"1252_CR119","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01516710","volume":"9","author":"F Reinitzer","year":"1888","unstructured":"Reinitzer F (1888) Contributions to the knowledge of cholesterol. Monatsh Chem 9:421\u2013441","journal-title":"Monatsh Chem"},{"issue":"15","key":"1252_CR120","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2165\/00003495-200767150-00001","volume":"67","author":"AB Reiss","year":"2007","unstructured":"Reiss AB, Wirkowski E (2007) Role of HMG-CoA reductase inhibitors in neurological disorders. Drugs 67(15):2111\u20132120","journal-title":"Drugs"},{"issue":"19","key":"1252_CR121","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/01.CIR.0000100688.17280.E6","volume":"108","author":"PM Ridker","year":"2003","unstructured":"Ridker PM (2003) Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein rationale and design of the JUPITER trial. Circulation 108(19):2292\u20132297","journal-title":"Circulation"},{"issue":"20","key":"1252_CR122","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347(20):1557\u20131565","journal-title":"N Engl J Med"},{"issue":"6","key":"1252_CR123","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","volume":"4","author":"K Riento","year":"2003","unstructured":"Riento K, Ridley AJ (2003) Rocks, multifunctional kinases in cell behavior. Nat Rev Mol Cell Biol 4(6):446\u2013456","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1252_CR124","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 340:115\u2013125","journal-title":"N Engl J Med"},{"key":"1252_CR125","first-page":"S1537","volume":"16","author":"L Roth","year":"2016","unstructured":"Roth L, Rombouts M, Schrijvers DM, Martinet W, De Meyer GRY (2016) Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture. Vasc Pharmacol 16:S1537\u2013S1891","journal-title":"Vasc Pharmacol"},{"issue":"12","key":"1252_CR126","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1593\/neo.07727","volume":"9","author":"G Sarrabayrouse","year":"2007","unstructured":"Sarrabayrouse G, Synaeve C, Leveque K, Favre G, Tilkin-Manam\u00e9 A-F (2007) Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA\/ROCK pathway in murine melanoma cells. Neoplasia 9(12):1078\u20131090","journal-title":"Neoplasia"},{"issue":"8","key":"1252_CR127","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/ars.2013.5524","volume":"20","author":"N Sawada","year":"2014","unstructured":"Sawada N, Liao JK (2014) Rho\/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statin s in atherosclerosis. Antioxid Redox Signal 20(8):1251\u20131267","journal-title":"Antioxid Redox Signal"},{"issue":"17","key":"1252_CR128","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/01.CIR.101.17.2030","volume":"101","author":"N Sawada","year":"2000","unstructured":"Sawada N, Itoh H, Ueyama K, Yamashita J, Doi K, Chun T-H, Inoue M, Masatsugu K, Saito T, Fukunaga Y (2000) Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 101(17):2030\u20132033","journal-title":"Circulation"},{"issue":"3","key":"1252_CR129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.RES.0000177090.07296.ac","volume":"97","author":"V Senthil","year":"2005","unstructured":"Senthil V, Chen SN, Tsybouleva N, Halder T, Nagueh SF, Willerson JT, Roberts R, Marian A (2005) Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 97(3):285\u2013292","journal-title":"Circ Res"},{"key":"1252_CR130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/aps.2015.87","volume":"37","author":"B-z Shao","year":"2016","unstructured":"Shao B-z, Han B-z, Zeng Y-x, Ding-feng S, Liu C (2016) The roles of macrophage autophagy in atherosclerosis. Acta Pharmacol Sin 37:150\u2013156","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"1252_CR131","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.fertnstert.2009.10.003","volume":"94","author":"I Sharma","year":"2010","unstructured":"Sharma I, Dhawan V, Mahajan N, Saha SC, Dhaliwal LK (2010) In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells. Fertil Steril 94(5):1639\u201346e1","journal-title":"Fertil Steril"},{"key":"1252_CR132","first-page":"S1","volume":"1","author":"A Shavakhi","year":"2014","unstructured":"Shavakhi A, Minakari M, Bighamian A, Sadeghian S, Shavakhi S, Khamisi N, Khodadustan M, Talebi M, Ataei B (2014) Statin efficacy in the treatment of hepatitis C genotype I. J Res Med Sci 1:S1\u2013S4","journal-title":"J Res Med Sci"},{"issue":"4","key":"1252_CR133","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/187152509789541864","volume":"7","author":"C Smaldone","year":"2009","unstructured":"Smaldone C, Brugaletta S, Pazzano V, Liuzzo G (2009) Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors. Cardiovasc Hematol Agents Med Chem 7(4):279\u2013294","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"s185","key":"1252_CR134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.2006.00690.x","volume":"114","author":"DL Sparks","year":"2006","unstructured":"Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J, Browne P (2006) Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease, results of the Alzheimer\u2019s Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol Scand 114(s185):3\u20137","journal-title":"Acta Neurol Scand"},{"key":"1252_CR135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2009.04.008","volume":"207","author":"AC Sposito","year":"2009","unstructured":"Sposito AC, Carvalhz LS, Cintra RM, et al. (2009) Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal. Atherosclerosis 207:191\u2013194","journal-title":"Atherosclerosis"},{"issue":"21","key":"1252_CR136","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1053\/euhj.2002.3174","volume":"23","author":"C Stefanadis","year":"2002","unstructured":"Stefanadis C, Toutouzas K, Vavuranakis M, et al. (2002) Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques. Eur Heart J 23(21):1664\u20131669","journal-title":"Eur Heart J"},{"key":"1252_CR137","unstructured":"Stone N J, Merz C N B, ScM F, Blum F C B, McBride F P, Eckel F R H, Schwartz F J S, Goldberg A C & Shero F S T (2013) ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol"},{"issue":"3","key":"1252_CR138","doi-asserted-by":"crossref","first-page":"e007280","DOI":"10.1136\/bmjopen-2014-007280","volume":"5","author":"J Sun","year":"2015","unstructured":"Sun J, Yuan Y, Cai R, Sun H, Zhou Y, Wang P, Wang S (2015) An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials. BMJ Open 5(3):e007280","journal-title":"BMJ Open"},{"key":"1252_CR139","unstructured":"Sweetman Sean C, Ed (2009) Cardiovascular drugs: Martindale, the complete drug reference (36th ed) London. Pharmaceutical Press pp 1155\u20131434 ISBN 978-0-85369-840-1"},{"issue":"10","key":"1252_CR140","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI13350","volume":"108","author":"M Takemoto","year":"2001","unstructured":"Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M, Liao JK (2001) Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108(10):1429\u20131437","journal-title":"J Clin Invest"},{"issue":"1","key":"1252_CR141","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.CIR.0000020682.73694.AB","volume":"106","author":"M Takemoto","year":"2002","unstructured":"Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106(1):57\u201362","journal-title":"Circulation"},{"issue":"7","key":"1252_CR142","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/ATVBAHA.112.300922","volume":"33","author":"S-I Tanaka","year":"2013","unstructured":"Tanaka S-I, Fukumoto Y, Nochioka K, Minami T, Kudo S, Shiba N, Takai Y, Williams CL, Liao JK, Shimokawa H (2013) Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol 33(7):1591\u20131600","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"1252_CR143","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/jama.2013.281348","volume":"310","author":"FC Taylor","year":"2013","unstructured":"Taylor FC, Huffman M, Ebrahim S (2013) Statin therapy for primary prevention of cardiovascular disease. JAMA 310(22):2451\u20132452","journal-title":"JAMA"},{"key":"1252_CR144","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1734-1140(11)70601-6","volume":"63","author":"M Tomaszewski","year":"2011","unstructured":"Tomaszewski M, Karolina M, Joanna S, Tomaszewska S, Czuczwar J (2011) Statin -induced myopathies. Pharmacol Rep 63:859\u2013866","journal-title":"Pharmacol Rep"},{"issue":"2","key":"1252_CR145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1535370212473696","volume":"238","author":"P Totoson","year":"2013","unstructured":"Totoson P, Fhayli W, Faury G, Korichneva I, Cachot S, Baldazza M, Ribuot C, P\u00e9pin J-L, L\u00e9vy P, Joyeux-Faure M (2013) Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia. Exp Biol Med 238(2):223\u2013232","journal-title":"Exp Biol Med"},{"key":"1252_CR146","doi-asserted-by":"crossref","unstructured":"Tousoulis D, Oikonomou E, Economou EK, Crea F, Kaski JC (2016) Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J:ehv759","DOI":"10.1093\/eurheartj\/ehv759"},{"issue":"11","key":"1252_CR147","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","volume":"110","author":"S Tsimikas","year":"2004","unstructured":"Tsimikas S, Witztum JL, Miller ER, Sasiela WJ, Szarek M, Olsson AG, Schwartz GG (2004) High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation 110(11):1406\u20131412","journal-title":"Circulation"},{"issue":"2","key":"1252_CR148","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2005.10.045","volume":"188","author":"T Uchiyama","year":"2006","unstructured":"Uchiyama T, Atsuta H, Utsugi T, Ohyama Y, Nakamura T, Nakai A, Nakata M, Maruyama I, Tomura H, Okajima F (2006) Simvastatin induces heat shock factor 1 in vascular endothelial cells. Atherosclerosis 188(2):265\u2013273","journal-title":"Atherosclerosis"},{"issue":"1","key":"1252_CR149","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1160\/TH05-01-0067","volume":"94","author":"A Undas","year":"2005","unstructured":"Undas A, Celinska-Lowenhoff M, Domagala TB, Iwaniec T, Dropinski J, Lowenhoff T, Szczeklik A (2005) Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia. Thromb Haemost 94(1):193\u2013199","journal-title":"Thromb Haemost"},{"issue":"5009","key":"1252_CR150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1126\/science.252.5009.1080","volume":"252","author":"PR Vagelos","year":"1991","unstructured":"Vagelos PR (1991) Are prescription drug prices high? Science (New York, NY) 252(5009):1080\u20131084","journal-title":"Science (New York, NY)"},{"key":"1252_CR151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/CBO9780511511677.002","volume-title":"Medicine, Science and Merck","author":"PR Vagelos","year":"2004","unstructured":"Vagelos PR, Galambos L (2004) Medicine, Science and Merck. Cambridge University Press, Cambridge, pp. 1\u2013301"},{"issue":"1","key":"1252_CR152","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-9150(02)00316-7","volume":"166","author":"M Ree Van de","year":"2003","unstructured":"Van de Ree M, Huisman M, Princen H, Meinders A, Kluft C (2003) Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 166(1):129\u2013135","journal-title":"Atherosclerosis"},{"issue":"10","key":"1252_CR153","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI119424","volume":"99","author":"AJ Vidal-Puig","year":"1997","unstructured":"Vidal-Puig AJ, Considine RV, Jimenez-Li\u00f1an M, Werman A, Pories WJ, Caro JF, Flier JS (1997) Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99(10):2416","journal-title":"J Clin Invest"},{"issue":"3","key":"1252_CR154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/CVM-2-3-111","volume":"2","author":"D Waters","year":"2001","unstructured":"Waters D, Schwartz GG, Olsson AG (2001) The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial, a new frontier for statins. Curr Control Trials Cardiovasc Med 2(3):111\u2013114","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"3","key":"1252_CR155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/mol.59.3.646","volume":"59","author":"S Wassmann","year":"2001","unstructured":"Wassmann S, Laufs U, B\u00e4umer AT, M\u00fcller K, Konkol C, Sauer H, B\u00f6hm M, Nickenig G (2001) Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells, involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 59(3):646\u2013654","journal-title":"Mol Pharmacol"},{"issue":"6","key":"1252_CR156","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1159\/000350111","volume":"31","author":"Y-M Wei","year":"2013","unstructured":"Wei Y-M, Li X, Xu M, Abais JM, Chen Y, Riebling CR, Boini KM, Li P-L, Zhang Y (2013) Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 31(6):925\u2013937","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"1252_CR157","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","volume":"7","author":"G Weitz-Schmidt","year":"2001","unstructured":"Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7(6):687\u2013692","journal-title":"Nat Med"},{"issue":"2","key":"1252_CR158","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1042\/BST0330346","volume":"33","author":"G Welsh","year":"2005","unstructured":"Welsh G, Hers I, Berwick D, Dell G, Wherlock M, Birkin R, Leney S, Tavare J (2005) Role of protein kinase B in insulin-regulated glucose uptake. Biochem Soc Trans 33(2):346\u2013349","journal-title":"Biochem Soc Trans"},{"issue":"10","key":"1252_CR159","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57(10):1439\u20131443","journal-title":"Arch Neurol"},{"issue":"3","key":"1252_CR160","doi-asserted-by":"crossref","first-page":"e59233","DOI":"10.1371\/journal.pone.0059233","volume":"8","author":"H Xiao","year":"2013","unstructured":"Xiao H, Qin X, Ping D, Zuo K (2013) Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity. PLoS One 8(3):e59233","journal-title":"PLoS One"},{"issue":"11","key":"1252_CR161","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1002\/art.22169","volume":"54","author":"H Xu","year":"2006","unstructured":"Xu H, Liu P, Liang L, Danesh FR, Yang X, Zhan YY, Z Yu X, Peng H, Sun L (2006) RhoA-mediated, tumor necrosis factor \u03b1\u2013induced activation of NF-\u03baB in rheumatoid synoviocytes: inhibitory effect of simvastatin. Arthritis Rheum 54(11):3441\u20133451","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1252_CR162","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCRESAHA.107.163493","volume":"102","author":"S Yagi","year":"2008","unstructured":"Yagi S, K-i A, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M (2008) Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II\u2013induced cardiovascular remodeling and renal insufficiency. Circ Res 102(1):68\u201376","journal-title":"Circ Res"},{"key":"1252_CR163","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/01.RES.0000268411.49545.9c","volume":"100","author":"M Yano","year":"2007","unstructured":"Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, et al. (2007) Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 100:1442\u20131451","journal-title":"Circ Res"},{"issue":"7","key":"1252_CR164","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2174\/18715273113129990085","volume":"12","author":"C Yavuz","year":"2013","unstructured":"Yavuz C, Demirtas S, Guclu O, Karahan O, Caliskan A, Yazici S, Mavitas B (2013) Rosuvastatin may have neuroprotective effect on spinal cord ischemia reperfusion injury. CNS Neurol Disord Drug Targets 12(7):1011\u20131016","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"1252_CR165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord 6(1):19\u201333","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"1252_CR166","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/phrs.2001.0922","volume":"45","author":"I Zelvyte","year":"2002","unstructured":"Zelvyte I, Dominaitiene R, Crisby M, Janciauskiene S (2002) Modulation of inflammatory mediators and PPAR \u03b3 and NF\u03ba\u03b2 expression by pravastatin in response to lipoproteins in human monocytes in-vitro. Pharmacol Res 45(2):147\u2013154","journal-title":"Pharmacol Res"},{"issue":"3","key":"1252_CR167","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1677\/erc.1.01012","volume":"12","author":"W Zhong","year":"2005","unstructured":"Zhong W, Liang Y, Wang C, Chang T, Lee W (2005) Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA\/ROCK signaling. Endocr Relat Cancer 12(3):615\u2013629","journal-title":"Endocr Relat Cancer"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-016-1252-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-016-1252-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-016-1252-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T18:26:38Z","timestamp":1692296798000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-016-1252-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,5]]},"references-count":167,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1007\/s00210-016-1252-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,5]]}}}